VIA
CTIC

Vantage Investment Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Vantage Investment Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-80
Closed – – 895
2016
Q2 		$0 Hold
80
– – ﹤0.01% 943
2016
Q1 		$0 Hold
80
– – ﹤0.01% 890
2015
Q4 		$1K Hold
80
– – ﹤0.01% 763
2015
Q3 		$1K Hold
80
– – ﹤0.01% 773
2015
Q2 		$2K Sell
80
-80
-50% -$1.54K ﹤0.01% 701
2015
Q1 		$3K Buy
160
+80
+100% +$1.8K ﹤0.01% 752
2014
Q4 		$2K Hold
80
– – ﹤0.01% 725
2014
Q3 		$2K Hold
80
– – ﹤0.01% 680
2014
Q2 		$2K Hold
80
– – ﹤0.01% 671
2014
Q1 		$3K Hold
80
– – ﹤0.01% 597
2013
Q4 		$2K Buy
+80
New +$1.46K ﹤0.01% 602

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return